Wordt geladen...
AT-01 PHASE I TRIAL OF DOSE ESCALATED RADIOSURGERY PLUS BEVACIZUMAB IN PATIENTS WITH RECURRENT/PROGRESSIVE GLIOBLASTOMA
BACKGROUND: Management of recurrent glioblastoma (rGBM) after standard initial therapy remains one of the most difficult challenges in oncology. Prior use of salvage stereotactic radiosurgery (SRS) for rGBM often involved maximum prescription doses defined by RTOG 90-05. We performed a prospective P...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Oxford University Press
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4217786/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou237.1 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|